The Impact of Case Management on Reducing Readmission for Patients Diagnosed With Heart Failure and Diabetes

Khalilah M McCants1, Kathryn B Reid, Ishan Williams

  • 1Khalilah M. McCants, DNP, MSN, RN-BC, is from School of Nursing, University of Virginia, and competencies that comprise Dr. McCants' nursing philosophy are as follows: (1) ability to design and lead, (2) effective management, and (3) ability to convert data into useful information. As an expert in her field as a nurse leader, Dr. McCants is devoted to making a domestic and global difference in the health of individuals. Kathryn B. Reid, PhD, RN, FNP-C, is from University of Virginia and is associate professor of nursing. She has received awards for excellence in teaching, innovative teaching strategies, professional service, and leadership as a 2005 Fellow in the AACN Leadership in Academic Nursing Program. Her research focuses on diabetes self-management education, and she maintains an active clinical practice as an FNP. Ishan Williams, PhD, FGSA, is an Associate Professor at the University of Virginia, School of Nursing. Her current research focuses on quality of life issues among older adults with dementia and their family caregivers, chronic disease management for older adults with Type 2 diabetes, and a study on the link between cognition and vascular problems among older African American adults. D. Elise Miller, MSN, LNHA, RN, is from Sibley Memorial Hospital. She has health care experience within hospitals, skilled nursing facilities, private insurers, and HMOs. She has a master's degree in nursing and is a Licensed Nursing Home Administrator. Currently, Ms. Miller works at Sibley Memorial Hospital where she has been the Renaissance Administrator since 2010 and the Director of Case Coordination since 2002. Ms. Miller has held case management leadership positions for MAMSI, Kaiser Permanente, and Health Management Strategies. She coauthored the chapter: Managed Care and New Roles for Nursing: Utilization and Case Management in a Health Maintenance Organization, Managing Nursing Care: Promise and Pitfalls, Series on Nursing Administration in 1993. Richard Rubin, MD, completed his BA and MD degrees at the Johns Hopkins University, and his cardiology training at Georgetown University. He is the Chief of Cardiology at Sibley Memorial Hospital in Washington, DC. He also serves as the hospital's physician advisor for utilization review, clinical resources management, and documentation improvement. Suzanne Dutton, MSN, DNP(c), RN, GNP-BC, works as a geriatric advanced practice nurse and NICHE coordinator at Sibley Memorial Hospital. She received her BSN, RN, at Fairfield University, MSN, GNP, from Yale University, and is currently enrolled as a doctorate student at Johns Hopkins School of Nursing.

Abstract

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
239
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
812
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
885
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.1K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
751
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
289